Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect?

The ChAdOx1 nCoV-19 vector vaccine (Vaxzevria, AstraZeneca, Cambridge, UK) was developed at Oxford University and is considered safe for the administration in lactating mothers. Nevertheless, as a novel vaccine, there are gaps in the knowledge regarding possible adverse events in breastfeeding infan...

Full description

Bibliographic Details
Main Author: Diogo, Patrícia (author)
Other Authors: Correia, Gil (author), Martins, João B. (author), Soares, Rui (author), Palma, Paulo J. (author), Santos, João Miguel (author), Gonçalves, Teresa (author)
Format: article
Language:eng
Published: 2022
Subjects:
AstraZeneca
COVID-19 vaccines
breastfeeding
cutaneous reaction
lactation
Online Access:http://hdl.handle.net/10316/100133
Country:Portugal
Oai:oai:estudogeral.sib.uc.pt:10316/100133

Internet

http://hdl.handle.net/10316/100133

Similar Items